(8alpha,9beta,11beta,14beta,20R,23S,24R)-11,23,24,25-Tetrahydroxydammar-13(17)-en-3-one

Basic Information

View in Editor

CAS Number

19885-10-0

Molecular Formula

C30H50O5

Molecular Weight

490.73 g/mol

Basic Physical Properties

Physical State

White powder

Melting Point

90-91 ºC

Boiling Point

629.302 ℃ at 760 mmHg

Solubility

,Methanol

SMILES

View in Editor

O[C@H]([C@H](C(O)(C)C)O)C[C@H](C1=C2C[C@H](O)[C@@H]3[C@]([C@]2(CC1)C)(C)CC[C@@H]1[C@]3(C)CCC(=O)C1(C)C)C

InChI

InChI=1S/C30H50O5/c1-17(15-21(32)25(34)27(4,5)35)18-9-13-29(7)19(18)16-20(31)24-28(6)12-11-23(33)26(2,3)22(28)10-14-30(24,29)8/h17,20-22,24-25,31-32,34-35H,9-16H2,1-8H3/t17-,20+,21+,22+,24+,25-,28+,29+,30+/m1/s1

InChIKey

HNOSJVWYGXOFRP-UNPOXIGHSA-N

LogP

4.794500000000005

Topological Polar Surface Area

97.99000000000001 Å²

Hydrogen Bond Donor/Acceptor

4 / 5

Complexity

904

Safety Information

View Safety Information

Storage Conditions

-20℃

Synonyms & References

English

Alisol A
(23S,24R)-11b,23,24,25-Tetrahydroxydammar-13(17)-en-3-one
Alisol-A
WAKO018-20681
(23S,24R)- 1β,23,24,25-Tetrahydroxy-8α,9β,14β-daMMar-13(17)-en-3-one
(8α,9β,11β,14β,23S,24R)-11,23,24,25-TetrahydroxydaMMar-13(17)-en-3-one
(8α,9β,14β,23S,24R)-11β,23,24,25-Tetrahydroxy-5α-dammar-13(17)-en-3-one
DaMMar-13(17)-en-3-one, 11, 23, 24, 25-tetrahydroxy-, (8α,9β,11,β 14β, 23S, 24R)-
(10S,11S)-11-Hydroxy-4,4,8,10,14-pentamethyl-17-[(2R,4S,5R)-4,5,6-trihydroxy-6-methylheptan-2-yl]-1,
Q63408699
0220AB
BDBM50130907
s9277
N2021
885A100
(8α,9β,11β,14β,23S,24R)-11,23,24,25-Tetrahydroxydammar-13(17)-en-3-one

MDL Number

MFCD09953906

FAQ

What regulatory guidelines apply to (8alpha,9beta,11beta,14beta,20R,23S,24R)-11,23,24,25-Tetrahydroxydammar-13(17)-en-3-one (CAS: 19885-10-0)?

This compound (CAS 19885-10-0) falls under the scope of REACH regulations in the EU, requiring registration if used in quantities above certain thresholds. For workplace safety, it must comply with the GHS classification, which includes specific handling and labeling requirements. In the US, the FDA and EPA may regulate its use in pharmaceuticals and environmental releases, respectively.

Are there alternatives to (8alpha,9beta,11beta,14beta,20R,23S,24R)-11,23,24,25-Tetrahydroxydammar-13(17)-en-3-one (CAS: 19885-10-0) in synthesis?

There are alternative reagents and synthetic routes that can be used to prepare similar compounds. For instance, dammarane derivatives with different functional groups can be synthesized using various isomers and analogs. Common alternatives include using 20(R)-dammar-20,25-diene-3-one as a precursor, which can be manipulated through various transformations.

What is the market or research trend for (8alpha,9beta,11beta,14beta,20R,23S,24R)-11,23,24,25-Tetrahydroxydammar-13(17)-en-3-one (CAS: 19885-10-0)?

The market for this compound shows growing interest in its potential pharmaceutical applications. Research trends are focused on its use as a bioactive molecule with anti-inflammatory and anti-tumor properties. However, due to its complex structure, the cost and availability remain significant challenges. Emerging research focuses on developing more efficient synthesis methods and understanding its biological mechanisms.

How should waste containing (8alpha,9beta,11beta,14beta,20R,23S,24R)-11,23,24,25-Tetrahydroxydammar-13(17)-en-3-one (CAS: 19885-10-0) be handled?

Waste containing this compound should be collected in appropriate containers and managed according to local environmental regulations. Incineration is a common disposal method, but it must be conducted in a controlled manner to prevent the release of harmful substances. Alternatively, professional waste disposal services can be used, ensuring compliance with both regulatory and environmental protection standards. Adequate precautions should be taken to protect the environment and human health during handling and disposal.